# US 2010/0166822 A1 · Adhesive cartilage implant

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0166822 A1
- Document ID: US20100166822A1
- Status: Published application
- Kind: A1
- Application number: 12/319,129
- Filed: 2008-12-31
- Published: 2010-07-01
- Earliest claimed: 2008-12-31
- Assignees: Howmedica Osteonics Corp.
- Inventors: Lin Song
- Web page: https://patentgrep.com/patent/US20100166822A1

## CPC

- A61F 2/30756: {Cartilage endoprostheses (A61F2/3603 takes precedence)}
- A61L 27/227: {Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24}
- A61L 27/34: Macromolecular materials
- A61L 27/3817: {Cartilage-forming cells, e.g. pre-chondrocytes}
- A61L 27/3852: {Cartilage, e.g. meniscus}
- A61L 27/3895: {using specific culture conditions, e.g. stimulating differentiation of stem cells, pulsatile flow conditions}
- A61F 2/3094: {Designing or manufacturing processes}
- A61F 2002/30762: {Means for culturing cartilage}
- A61L 2430/06: for cartilage reconstruction, e.g. meniscus
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)

## Abstract

A method of producing a cartilage implant which may include coating a substrate with a thermo-sensitive polymer, seeding the polymer with a cell suspension comprising cells that may differentiate into chrondocyte-like cells, wherein the seeding may be conducted at a first temperature, culturing the cell suspension at an increased temperature, whereby cells in the suspension may adhere to the polymer and differentiate into chrondrocyte-like cells, which may form a cartilagenous implant, and decreasing the temperature of the polymer which may allow detachment of the implant from the polymer. The present invention may also include an implant based on this method. The invention may further include a cartilage implant for use in a patient in need thereof, which may include a random three-dimensional configuration of differentiated cells, which may have a natural adhesion surface on at least a portion of the outer surface of the three-dimensional configuration.

## Claims

### Claim 1

A method of producing a cartilage implant, comprising:
a) coating a substrate with a thermo-sensitive polymer;
b) seeding the polymer with a cell suspension comprising cells that differentiate into chrondocyte-like cells, wherein said seeding is conducted at a first temperature;
c) culturing the cell suspension at an increased temperature, whereby cells in the suspension adhere to the polymer and differentiate into chrondrocyte-like cells, thus forming a cartilagenous implant; and
d) decreasing the temperature of c), thus allowing detachment of the implant from the polymer.

### Claim 2 (depends on 1)

The method of claim 1, wherein the thermo-sensitive polymer is selected from the group consisting of poly(N-isopropylacrylamide), polycaprolactone, 2-ethoxyethyl ether, and 2-phenoxyethyl vinyl ether copolymer.

### Claim 3 (depends on 1)

The method of claim 1, wherein the cells are selected from the group consisting of stem cells, progenitor cells, embryonic stem cells, bone marrow cells, human bone marrow stromal cells, mesenchymal cells, chondrocytes, chondroblasts, and osteoblasts.

### Claim 4 (depends on 1)

The method of claim 1, wherein the cells are in a three-dimensional configuration.

### Claim 5 (depends on 4)

The method of claim 4, wherein the three-dimensional configuration of the cells is random.

### Claim 6 (depends on 1)

The method of claim 1, wherein the first temperature is a nonphysiological temperature.

### Claim 7 (depends on 6)

The method of claim 6, wherein the nonphysiological temperature is less than about 28° C.

### Claim 8 (depends on 1)

The method of claim 1, wherein the increased temperature is a physiological temperature.

### Claim 9 (depends on 8)

The method of claim 8, wherein the physiological temperature is about 36.1° C. to about 37.8° C.

### Claim 10 (depends on 1)

The method of claim 1, wherein the temperature at which the implant detaches from the thermo-sensitive polymer is a nonphysiological temperature.

### Claim 11 (depends on 10)

The method of claim 10, wherein the nonphysiological temperature is less than about 28° C.

### Claim 12 (depends on 1)

The method of claim 1, wherein the implant released from the thermo-sensitive polymer comprises an adhesive surface.

### Claim 13 (depends on 12)

The method of claim 12, wherein the adhesive surface comprises a natural adhesion surface.

### Claim 14 (depends on 13)

The method of claim 13, wherein the natural adhesion surface comprises integrins.

### Claim 15 (depends on 1)

The method of claim 1, further comprising e) removing the detached implant from the substrate and thermo-sensitive polymer and implanting the detached implant into a patient in need thereof.

### Claim 16 (depends on 1)

A cartilage implant for regenerating joint defects in a patient in need thereof, comprising a three-dimensional configuration of cells produced using the method of claim 1.

### Claim 17

A cartilage implant for use in a patient in need thereof, comprising a random three-dimensional configuration of differentiated cells, wherein at least a portion of the outer surface of the three-dimensional configuration comprises a natural adhesion surface.

### Claim 18 (depends on 17)

The cartilage implant of claim 17, wherein the natural adhesion surface comprises integrins.

### Claim 19 (depends on 18)

The cartilage implant of claim 18, wherein the natural adhesion surface further comprises extracellular matrix molecules.

### Claim 20 (depends on 17)

The cartilage implant of claim 17, wherein the natural adhesion surface of the implant is capable of adhering to a cartilage defect in a patient in need thereof.
